Serum Institute of India rejected charges that a COVID-19 vaccine candidate has serious side effects after vaccine administration. The incident took place on November 29. The vaccine major threatened to seek heavy damages for “malicious” allegations.
A 40-year-old man who took part in the ‘Covidshield’ vaccine trial in Chennai has alleged serious side effects, including a virtual neurological breakdown and impairment of cognitive functions and has sought ₹5 crore compensation. These details were revealed in a legal notice addressed to Serum Institute and others. The candidate also sought a halt to the trial.
“The allegations in the notice are malicious and misconceived. While the Serum Institute of India is sympathetic with the volunteer’s medical condition, there is absolutely no correlation with the vaccine trial and the medical condition of the volunteer,” Serum Institute of India said in a statement.
The institute said that the candidate placed the blames on the vaccine rather than addressing his underlying medical problems. “It is evident that the intention behind the spreading of such malicious information is an oblique pecuniary motive. The Serum Institute of India, will seek damages in excess of 100 crore for the same and will defend such malicious claims,” the statement by Serum Institute read.
Serum Institute of India has collaborated with Oxford University and Astra Zeneca for ‘Covidshield’- COVID-19 vaccine. They are conducting trials in India.
Image Source: Reuters